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Background & Aims: The proton pump H1,K1-adenosine
triphosphatase (H1,K1-ATPase) of parietal cells is the
major humoral autoantigen in both human and experi-
mental autoimmune gastritis (AIG) characterized by an
inflammatory infiltrate in the gastric mucosa and loss of
parietal cells. The aim of this study was to detect H1,K1-
ATPase–specific T cells in the gastric mucosa of patients
with AIG and to define their functional properties.
Methods: In vivo–activated T cells from the infiltrates of
the gastric mucosa of 5 patients with AIG were isolated
and cloned. The ability of gastric T-cell clones to prolif-
erate and to produce cytokines in response to H1,K1-
ATPase, as well as their expression of B-cell help,
perforin-mediated cytotoxicity, and Fas-Fas ligand–me-
diated apoptosis in target cells, were assessed. Results:
A proportion (25%) of the CD41 clones from the gastric
corpus of AIG patients proliferated in response to por-
cine H1,K1-ATPase. Most of these clones (88%) showed
a Th1 profile, whereas a few secreted both Th1 and Th2
cytokines. Virtually all of the H1,K1-ATPase–specific
clones produced tumor necrosis factor a and provided
substantial help for B-cell immunoglobulin production,
and most of them expressed perforin-mediated cytotox-
icity against antigen-presenting cells and induced Fas-
Fas ligand–mediated apoptosis in target cells.
Conclusions: Activation of proton pump–specific Th1 cy-
totoxic/proapoptotic T cells in the gastric mucosa can
represent an effector mechanism for the target cell
destruction in AIG.
Chronic autoimmune gastritis (AIG) is an inflamma-tory disorder of the gastric corpus that does not
usually result in overt symptoms until development of
mucosal atrophy and malabsorption of cobalamin and
iron. Subclinical AIG is often suggested by the detection
of anti–parietal cell autoantibodies (PCA) in the serum of
patients with suspected autoimmune endocrine disease.1
Thyroid disorders, such as Graves disease and Hashimoto
thyroiditis, show a striking association with pernicious
anemia and/or AIG, particularly in women older than 40
years.2,3 AIG and PCA were found in a proportion of
women with postpartum thyroiditis, and examination of
biopsy specimens from the gastric corpus of these pa-
tients showed moderate corpus atrophy, mucosal infil-
tration by CD4 T cells and macrophages, and abundant
epithelial expression of HLA-DR.4
In AIG patients, with or without pernicious anemia,
H1,K1-adenosine triphosphatase (ATPase), the proton
pump of parietal cells, is the key autoantigen recognized
by PCA.5–9 Gastric H1,K1-ATPase is also the ma-
jor autoantigen in experimental autoimmune gastritis
(EAIG), an organ-specific autoimmune disease that can
be elicited in nonthymectomized animals by immuniza-
tion with either gastric mucosal extracts or purified
gastric H1,K1-ATPase10–15 or by neonatal thymec-
tomy.16,17 These models of AIG are characterized by an
inflammatory infiltrate in the gastric mucosa, subsequent
loss of acid-secreting parietal cells and zymogenic cells,
and late appearance of circulating autoantibodies di-
rected against the a and b subunits of parietal cell
H1,K1-ATPase.13–15 The gastric mononuclear infiltrate
contains both CD4 and CD8 T cells, macrophages, and B
cells,18 and the histopathologic lesions are similar to
those observed in humans affected with chronic AIG and
pernicious anemia.18,19 Although many studies on hu-
man AIG and pernicious anemia have examined autoan-
Abbreviations used in this paper: AIG, autoimmune gastritis; APC,
antigen-presenting cell; EAIG, experimental autoimmune gastritis;
EBV, Epstein–Barr virus; H1,K1-ATPase, H1,K1-adenosine triphos-
phatase; Hp-CG, Helicobacter pylori–induced chronic gastritis; IFN,
interferon; mAb, monoclonal antibody; PCA, parietal cell autoantibody;
PMA, phorbol-12-myristate 13-acetate; TNF, tumor necrosis factor.




tibody response to H1,K1-ATPase, no information is
available on the possible pathogenic mechanisms medi-
ated by T cells, eventually leading to parietal cell de-
struction.
The aims of this study were (1) to provide evidence for
the presence of H1,K1-ATPase–specific T cells in the
gastric mucosa of patients with AIG, (2) to define these
cells’ cytokine pattern and mode of delivering help for
B-cell antibody production, and (3) to assess the cytolytic




Five women (mean age, 48; range, 33–56 years) from
Tuscany with type A chronic AIG and 5 women (mean age,
51; range, 40–59 years) with Helicobacter pylori–induced un-
complicated type B chronic gastritis without atrophy (Hp-CG)
provided their informed consent for this study, which was
performed after the approval by the local Ethical Committee.
All AIG patients had serum gastric PCA, as assessed by
indirect immunofluorescence. These autoantibodies proved to
be specific for gastric H1,K1-ATPase, as assessed by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis immuno-
blotting with the purified antigen.20 None of the AIG patients
had intrinsic factor autoantibodies or hematologic abnormali-
ties, and their vitamin B12 serum levels ranged between 345
and 480 pg/mL. One patient (G.A.) was undergoing treatment
with low-dose methimazole for concomitant Graves disease,
and 2 patients (C.A. and S.M.) were receiving treatment with
levothyroxine for chronic thyroiditis and hypothyroidism.
These 3 patients also had thyroid peroxidase autoantibodies in
their serum. All of the AIG patients had negative results on
both serology (Helicoblot 2.0; Genelabs Diagnostic, Geneva,
Switzerland) and 13C-urea breath test, which assess previous
and/or actual H. pylori infection. In contrast, the 5 control
patients with Hp-CG were infected with CagA1VacA1 H.
pylori type I strains and were positive for anti-CagA serum
immunoglobulin (Ig) G antibodies but negative for PCA or
other organ-specific autoantibodies. Biopsy specimens ob-
tained from the gastric antrum and corpus of AIG and HpCG
patients were used for diagnosis (histology and typing of H.
pylori strain) and culture of mucosa-infiltrating T lymphocytes.
Generation of Gastric T-Cell Clones
Biopsy specimens were cultured for 7 days in RPMI
1640 medium supplemented with human interleukin (IL)-2
(50 U/mL; Eurocetus, Milan, Italy) to expand in vivo–activated
T cells.21 Mucosal specimens were then disrupted, and single
T-cell blasts were cloned under limiting dilution (0.3 cells/
well), as described previously.21,22 Each clone was screened for
responsiveness to porcine H1,K1-ATPase or albumin (Sigma-
Aldrich, Milan, Italy) and H. pylori by measuring [3H]thymi-
dine uptake after 60 hours of stimulation with medium,
different concentrations of H1,K1-ATPase (0.3 mg/mL being
optimal), porcine albumin (5 mg/mL), or H. pylori lysate
(aqueous extract of NCTC11637 strain, 0.5–50 mg/mL; kindly
provided by Dr. John L. Telford, Chiron Vaccines, Siena, Italy)
in the presence of irradiated autologous mononuclear cells as
antigen-presenting cells (APCs).21 Gastric H1,K1-ATPase was
purified from pig gastric mucosa as previously reported.23 The
major histocompatibility complex (MHC) class II restriction of
H1,K1-ATPase recognition by T-cell clones was determined
with either a murine monoclonal antibody (mAb) reacting
with all major histocompatibility class II HLA-DR and -DP
antigens and most DQ molecules (clone TU39; Pharmingen,
San Diego, CA) or allogeneic irradiated APCs (HLA mis-
matched with the T-cell donors). Autologous irradiated APCs
(5 3 104) were incubated first with 5 mg/mL anti-MHC class
II mAb or isotype (IgG2a) control for 1 hour at 37°C, then
with 0.3 mg/mL H1,K1-ATPase, and finally with 5 3 104/0.2
mL responder clonal T-cell blasts in triplicate cultures;
[3H]thymidine uptake was measured after 60 hours. Virtually
all H1,K1-ATPase– or H. pylori–specific clones showed indi-
vidual patterns of response to superantigens (4 staphylococcal
enterotoxins: SEA, SEB, SED, and SEE in the presence of
allogeneic APCs), suggesting a difference in their T cell–
reactive Vb-chain expression.
Cytokine Profile of Gastric T-Cell Clones
To assess the cytokine production of H1,K1-ATPase–
or H. pylori–specific Th clones, 106 T-cell blasts of each clone
were cocultured in duplicate cultures for 48 hours in 1 mL
medium with 5 3 105 irradiated autologous peripheral blood
mononuclear cells as APCs and H1,K1-ATPase or H. pylori
lysate.21 The H1,K1-ATPase (0.3 mg/mL) and H. pylori lysate
(10 mg/mL) found to be optimal for proliferation were also
optimal for induction of cytokine production. To induce cy-
tokine production by gastric T-cell clones in the absence of
APCs, T-cell blasts were stimulated for 36 hours with phorbol-
12-myristate 13-acetate (PMA, 10 ng/mL) in microwells
coated with anti-CD3 mAb, as previously reported.22 Dupli-
cate samples of each supernatant were assayed for interferon
(IFN-g, IL-4, IL-5, and tumor necrosis factor [TNF]-a; Bio-
Source International, Camarillo, CA). Supernatants showing
IFN-g, IL-4, IL-5, and TNF-a levels 5 SD over the mean levels
in control supernatants derived from irradiated feeder cells
alone were regarded as positive. T-cell clones able to produce
IFN-g but not IL-4 or IL-5 were categorized as Th1; clones
able to produce IL-4 and/or IL-5 but not IFN-g as Th2; and
clones producing both IFN-g and IL-4 or IL-5 as Th0.
Assay for Helper Function to B Cells by
Gastric T-Cell Clones
B cell– enriched suspensions were prepared by a dou-
ble-step rosetting with neuraminidase-treated sheep red blood
cells, as previously described.24 Peripheral blood B cell– en-
riched suspensions usually consisted of 68%–87% B cells,
9%–21% monocytes, and ,1% T cells. They are referred to as
B cells. The cell culture system used to assess the ability of
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antigen-stimulated T-cell clones to induce polyclonal B-cell
activation and Ig synthesis was performed in duplicate tubes
containing complete medium supplemented with 10% fetal
calf serum. B cells (5 3 104) were cultured alone or with
autologous clonal T-cell blasts (5 3 104) in the absence or
presence of H1,K1-ATPase (0.3 mg/mL) or porcine albumin (5
mg/mL). After 10 days, culture supernatants were collected
and assayed for their IgM, IgG, and IgA content by immuno-
radiometric assays, as previously described.24
Perforin-Mediated Cytolytic Activity
Perforin-mediated cytolytic activity of T-cell clones
was assessed as previously reported.21 T-cell blasts of H1,K1-
ATPase–specific clones were incubated at ratios of 10, 5, and
2.5 to 1 with 51Cr-labeled autologous Epstein–Barr virus
(EBV)-transformed lymphoblastoid B cells (EBV-B cells) pre-
incubated with H1,K1-ATPase or porcine albumin or H. pylori
lysate (control antigens). After centrifugation to favor cell-to-
cell contact, microplates were incubated for 8 hours at 37°C,
and 0.1 mL of supernatant was removed for measurement of
51Cr release. Maximum release (MR) was obtained by treating
target cells with 0.1 mL of 1 mol/L HCl. Spontaneous release (SR)
was determined in microcultures without T cells. Specific lysis
was calculated according to the formula: Percent Specific Lysis 5
100 3 (Experimental Release 2 SR)/(MR 2 SR). Cultures in
which 51Cr release exceeded the mean SR by more than 5 SD were
considered positive for cytolytic activity. The ability of H1,K1-
ATPase–specific T-cell clones to express perforin-mediated cyto-
toxicity was confirmed in a lectin-dependent assay against 51Cr-
labeled P815 murine mastocytoma cells at effector-to-target ratios
of 10, 5, and 2.5 to 1 in the presence of phytohemagglutinin (1%,
vol/vol), as previously described.21
Fas-Fas Ligand–Mediated Apoptotic Killing
The ability of H1,K1-ATPase–specific gastric T-cell
clones to induce Fas-Fas ligand–mediated apoptosis was assessed
using Fas1 Jurkat cells as target.25 T-cell blasts from each clone
were cocultured with 51Cr-labeled Jurkat cells at an effector-to-
target ratio of 10, 5, and 2.5 to 1 for 18 hours in the presence of
PMA (10 ng/mL) and ionomycin (1 mmol/L). Specific lysis was
calculated according to the formula reported above. To block
Fas–Fas ligand interaction, the anti-Fas antagonistic mAb M3
(Immunex Corp., Seattle, WA)26 was used at 5 mg/mL final
concentration in a 30-minute pretreatment of 51Cr-labeled Jurkat
cells. The anti-Fas or its isotype (IgG1) control was also added
during the cytolytic assay at 2 mg/mL final concentration.
Results
Reactivity to H1,K1-ATPase and Cytokine
Profile of Gastric T-Cell Clones
In vivo–activated T cells present in the lympho-
cytic infiltrates of the gastric antrum and corpus of 5
PCA-positive patients with chronic AIG without evi-
dence of previous or actual infection with H. pylori were
isolated and cloned. Likewise, control T-cell clones were
generated from in vivo–activated T cells isolated from
the gastric antrum and corpus of 5 PCA-negative, age-
and sex-matched patients with uncomplicated Hp-CG.
A total number of 175 CD41 and 55 CD81 clones were
obtained from the biopsy specimens of the gastric corpus
of AIG patients, whereas a total of 105 CD41 and 38
CD81 T-cell clones were generated from specimens of
the gastric antrum of the same patients with AIG. The
biopsies of corpus and antrum in patients with Hp-CG
yielded 73 CD41 plus 31 CD81 and 186 CD41 plus 22
CD81 T-cell clones, respectively. When assessed for their
ability to proliferate in response to H1,K1-ATPase or H.
pylori lysate in the presence of irradiated autologous
APCs, none of the CD81 T-cell clones from patients
with either AIG or Hp-CG showed significant reactivity
to either of the antigens. Likewise, although 49 of 186
CD41 clones from the antrum (26%) and 1 of 73 CD41
clones (1.3%) from the corpus of patients with Hp-CG
showed significant proliferation to H. pylori lysate (Table
1), none of these gastric T-cell clones proliferated in
response to H1,K1-ATPase at different concentrations.
In contrast, 43 of the 175 CD41 clones from the corpus
(25%) and 3 of the 105 CD41 clones from the antrum
(2.8%) of patients with AIG showed substantial prolif-
eration in response to porcine H1,K1-ATPase (Figure 1),
with a peak response to 0.3 mg/mL of this antigen
preparation (Figure 2). In the 5 AIG patients, the pro-
portion of H1,K1-ATPase–specific CD41 clones isolated
from the corpus ranged between 13% and 32%, whereas
few H1,K1-ATPase–specific CD41 clones could be iso-
lated from the antrum of only 1 patient (C.A.). Control
proliferation experiments with porcine albumin showed
that such T-cell clones responded only to porcine gastric
H1,K1-ATPase (Figure 1). Blocking experiments with
anti-MHC class II mAb and antigen presentation by
allogeneic APCs showed that H1,K1-ATPase was rec-
ognized by reactive T-cell clones under MHC class II–
restricted conditions (Figure 3).
Upon stimulation with the specific antigen, 38 of the
43 H1,K1-ATPase–specific clones (88%) from the cor-
pus and the 3 H1,K1-ATPase–specific clones from the
antrum of patients with AIG produced IFN-g but nei-
ther IL-4 nor IL-5 (Th1 cytokine profile), whereas 5
H1,K1-ATPase–specific clones from the corpus (12%)
secreted both Th1- and Th2-type cytokines (Th0 profile;
Table 1 and Figure 4). In agreement with the results of
our previous studies21,27 in the series of H. pylori–specific
CD41 clones from the antrum of patients with Hp-CG,
61% expressed a Th0 profile and 39% a Th1 profile upon
stimulation with H. pylori lysate (Figure 4), the unique H.
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pylori–specific clone derived from the corpus also showing a
Th1 profile (Table 1). Of note, all H1,K1-ATPase–specific
clones produced high concentrations of TNF-a, particularly
upon stimulation with PMA plus insoluble anti-CD3 an-
tibody in the absence of APCs (mean 6 SE, 5.1 6 0.6
ng/mL per 106 T cells). This suggests that high TNF-a
production was a peculiar property of autoreactive gastric T
cells of patients with AIG because under the same experi-
mental conditions, in the series of H. pylori–specific T-cell
clones from patients with Hp-CG TNF-a–producing
clones were 78%, with a mean (6SE) production of 2.7 6
1.8 ng/mL per 106 T cells (t, 28.12; P , 0.05).
H1,K1-ATPase–Specific T-Cell Clones
Express Antigen-Dependent Help to
Autologous B Cells for Ig Production
The ability of H1,K1-ATPase–specific T-cell clones
to provide B-cell help for Ig synthesis was then investigated.
To this end, T-cell blasts of each clone were cocultured at
ratios of 0.2, 1, and 5 to 1 with autologous peripheral blood
B cells in the absence or presence of H1,K1-ATPase or
porcine albumin, and IgM, IgG, and IgA levels in cell-free
culture supernatants on day 10 were measured. In the
absence of the specific antigen, no increase in IgM, IgG, or
IgA production above the spontaneous levels measured in
cultures containing B cells alone was observed. In the
presence of H1,K1-ATPase and at a T-to-B cell ratio of 0.2
to 1, all of the H1,K1-ATPase–specific T-cell clones (from
either corpus or antrum) provided substantial help for Ig
production. At a 1-to-1 T-to-B cell ratio, H1,K1-ATPase–
dependent T-cell help for IgM, IgG, and IgA production by
B cells was remarkably higher (Figure 5). However, at a
5-to-1 T-to-B cell ratio, coculturing B cells with autologous
H1,K1-ATPase–specific T-cell clones in the presence of
H1,K1-ATPase resulted in much lower Ig synthesis (Fig-
ure 5).
H1,K1-ATPase–Specific T-Cell Clones Can
Induce Death in Target Cells via Both
Perforin- and Fas-Fas Ligand–Mediated
Pathways
Because most antigen-activated Th1 and Th0
clones express perforin-mediated cytotoxicity against au-
tologous APCs (e.g., antigen-pulsed B cells),24 the cyto-
Table 1. Antigen Specificit and Cytokine Secretion Profil of T-Cell Clones Derived From the Gastric Mucosa of Patients With






No. (%) of CD41 clones reactive to
% of H1,K1-ATPase–specifi T-cell
clones with the indicated profil
H1,K1-ATPase H. pylori lysate Th1 Th0 Th2
G.A.
Corpus 33 9 (27)a 0 100b 0 0
Antrum 22 0 0 0 0 0
C.A.
Corpus 34 8 (24) 0 88 12 0
Antrum 27 3 (11) 0 100 0 0
N.G.
Corpus 30 4 (13) 0 75 25 0
Antrum 19 0 0 0 0 0
S.M.
Corpus 41 13 (32) 0 77 23 0
Antrum 21 0 0 0 0 0
F.F.
Corpus 37 9 (24) 0 100 0 0
Antrum 16 0 0 0 0 0
All AIG cases
Corpus 175 43 (25) 0 88 12 0
Antrum 105 3 (3) 0 100 0 0
Hp-CG cases (n 5 5)
Corpus 73 0 1 (1)
Antrum 186 0 49 (26)
a T-cell blasts from each clone (5 3 104) were seeded in triplicate cultures with irradiated autologous APCs (5 3 104) in the presence of medium
alone, H1,K1-ATPase (0.3 mg/mL), or H. pylori lysate (10 mg/mL). After 60 hours, [3H]thymidine uptake was measured and expressed as
mitogenic index.
bT-cell blasts from each clone (106) were cocultured with irradiated autologous APCs (5 3 105) in 1 mL in the presence of medium alone,
H1,K1-ATPase (0.3 mg/mL), or H. pylori lysate (10 mg/mL). After 48 hours, cell-free supernatants were assayed for their IFN-g, IL-4, and IL-5
content. Mean cytokine levels in culture supernatants of irradiated APCs alone were ,0.1 ng/mL IFN-g, ,0.03 ng/mL IL-4, and ,0.06 ng/mL
IL-5. T-cell clones able to produce IFN-g but not IL-4 or IL-5 were categorized as Th1; clones able to produce IL-4 and/or IL-5 but not IFN-g were
categorized as Th2; and clones producing both IFN-g and IL-4 or IL-5 were categorized as Th0.
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lytic potential of H1,K1-ATPase–specific T-cell clones
from patients with AIG was assessed by using H1,K1-
ATPase–pulsed 51Cr-labeled autologous EBV-B cells as
targets. At the effector-to-target ratio of 10 to 1, all 41
Th1 and 3 of 5 Th0 H1,K1-ATPase–specific clones lysed
H1,K1-ATPase–presenting autologous EBV-B cells,
whereas autologous EBV-B cells pulsed with porcine
albumin (Figure 6) or H. pylori lysate (data not shown)
and cocultured with the same clones were not lysed. The
ability of H1,K1-ATPase–specific clones to express per-
forin-mediated cytotoxicity was confirmed by a lectin-
dependent cytolytic assay against 51Cr-labeled P815
cells, in which only the same 2 Th0 clones failed to lyse
their targets (data not shown). Because activated effector
T cells can also kill their targets by inducing apoptosis
through Fas–Fas ligand interaction,25,28–30 the ability of
activated H1,K1-ATPase–specific T-cell clones to in-
duce 51Cr-release by Fas1 Jurkat cells undergoing apo-
ptosis was evaluated. Upon mitogen activation, 35 of 41
Th1 (85%) and 3 of 5 Th0 H1,K1-ATPase–specific
T-cell clones were able to induce apoptosis in target cells.
The role of Fas-Fas ligand interaction in this 51Cr release
was confirmed by its substantial inhibition (.50%) by a
blocking anti-Fas antibody (Figure 7).
Figure 1. Proliferative response to H1,K1-ATPase by gastric T-cell
clones derived from patients with AIG. In vivo–activated T cells were
recovered from biopsy specimens of gastric mucosa of patients with
AIG or Hp-CG and cloned by limiting dilution. T-cell blasts from each
clone were seeded in triplicate cultures with irradiated autologous
mononuclear cells (as APCs) in the presence of medium alone, por-
cine H1,K1-ATPase (0.3 mg/mL), porcine albumin (5 mg/mL), or H.
pylori lysate (5 mg/mL). After 60 hours, [3H]thymidine uptake was
measured and expressed as mitogenic index.
Figure 2. Dose-response curves of proliferative response to H1,K1-
ATPase by representative gastric T-cell clones derived from patients
with AIG (closed symbols ) and proliferative response to H. pylori lysate
by representative gastric T-cell clones derived from patients with
Hp-CG (open symbols ). T-cell blasts from each clone were seeded in
triplicate cultures with irradiated autologous mononuclear cells (as
APCs) in the presence of medium alone or graded concentrations of
porcine H1,K1-ATPase or H. pylori lysate. After 60 hours, [3H]thymi-
dine uptake was measured and expressed as mitogenic index.
Figure 3. HLA class II restriction of H1,K1-ATPase recognition by
gastric T-cell clones. HLA class II restriction was assessed either by
using irradiated HLA class II mismatched allogeneic APCs or by adding
in culture an mAb reacting with all major histocompatibility class II
HLA-DR and -DP antigens and most DQ molecules. Results obtained
with 6 representative H1,K1-ATPase–specifi gastric T-cell clones
from AIG patients are shown. Experimental conditions are reported in
Figure 1.
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Discussion
We have investigated the pathogenic mechanisms
of human AIG in this study. Data showed for the first
time that T cells specific for H1,K1-ATPase of parietal
cells are present in the gastric mucosa of patients with
AIG. These autoreactive T cells were found to be Th1
effector cells with cytolytic potential through both per-
forins and Fas–Fas ligand interaction, and we propose
that parietal cell loss in AIG proceeds through an auto-
immune T-cell attack. In vivo–activated T cells present
in the lymphocytic infiltrates of the lesional gastric mu-
cosa of 5 patients with chronic AIG were expanded in
vitro and efficiently cloned to assess their reactivity to
H1,K1-ATPase, as well as their functional profile. This
cloning procedure has proved useful and accurate for in
vitro studies of tissue-infiltrating T cells in various dis-
eases.31 In the clonal progenies of T cells from the gastric
corpus of all AIG patients, a noticeable proportion of
CD41 T-cell clones were reactive to porcine H1,K1-
ATPase under MHC-restricted conditions. Each patient
with AIG contributed an almost equal number of gastric
T-cell clones, whose functional features were consistently
shared by each patient. A few clones with the same
reactivity were also isolated from the antral mucosa in a
patient with AIG, suggesting that the gastric corpus, in
which disturbed parietal cell function and reduced acid
production usually occur, is the major target of autore-
active H1,K1-ATPase–specific gastric T cells. A reason-
able objection may be that the high proportion of
H1,K1-ATPase–specific T-cell clones merely reflects the
IL-2–induced selective expansion of 1 or few H1,K1-
ATPase–specific gastric T cells. However, such a possi-
bility is unlikely because the majority of H1,K1-
ATPase–specific T-cell clones expressed different T-cell
receptor Vb rearrangements, as indicated by their almost
individual patterns of response to 4 different staphylo-
Figure 4. IFN-g and IL-4 production induced by H1,K1-ATPase in gas-
tric T-cell clones derived from patients with AIG. To assess the cyto-
kine production of H1,K1-ATPase–specifi Th clones from patients
with AIG (F) or H. pylori–specifi Th clones from patients with Hp-CG
(E), 106 T-cell blasts of each clone were cocultured in duplicate
cultures for 48 hours in 1 mL medium with 5 3 105 irradiated
autologous peripheral blood mononuclear cells as APCs and H1,K1-
ATPase (0.3 mg/mL) or H. pylori lysate (10 mg/mL). Duplicate sam-
ples of each supernatant were assayed for IFN-g and IL-4 by appro-
priate assays. Dotted lines indicate 5 SD over the mean cytokine
levels in control supernatants derived from irradiated feeder cells
alone.
Figure 5. In vitro synthesis of IgM, IgG, and IgA induced in autologous
B cells by H1,K1-ATPase–specifi gastric T-cell clones stimulated with
the specifi antigen. Autologous peripheral blood B cells (5 3 104)
were cultured with T-cell blasts of each H1,K1-ATPase–specifi gastric
clone at T-to-B cell ratios of 0.2, 1, and 5 to 1 in the absence (h) or
presence of H1,K1-ATPase (■) or porcine albumin (E). After 10 days,
cell-free culture supernatants were assayed for their IgM, IgG, and IgA
content using appropriate immunoradiometric assays. The results
represent the mean (6SE) Ig levels induced by T-cell clones over the
spontaneous Ig production in cultures of B cells alone.
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coccal enterotoxin superantigens (data not shown). Thus,
it is reasonable to conclude that gastric autoimmunity
elicits a powerful local inflammatory response that re-
cruits and activates a large number of H1,K1-ATPase–
specific effector T cells. As expected on the basis of their
negative serology, 13C-urea breath test, and histology, no
patient with AIG had gastric T-cell reactivity to H. pylori
antigens, whereas in control patients affected with H.
pylori–induced chronic gastritis a number of CD41 T-
cell clones reactive to H. pylori antigens could be isolated
from the gastric antrum.21,27 On the other hand, in none
of the 5 patients with H. pylori–induced chronic gastritis
selected for their negative serology for organ-specific
autoimmunity did the same cloning procedure yield any
T-cell clones reactive to porcine H1,K1-ATPase, sug-
gesting that such a T-cell reactivity does not simply
result from an inflammatory process at the gastric level,
allowing foreign antigens (e.g., porcine food antigens) to
cross the mucosa and to be recognized by local T cells.
Rather, T-cell recognition of porcine H1,K1-ATPase at
the gastric level is specific for patients with gastric
autoimmunity and reasonably results from reactivity
against T-cell epitopes shared by both human and por-
cine H1,K1-ATPase. Previous studies have shown that
H1,K1-ATPase prepared from vesicular membranes iso-
lated from porcine gastric mucosa as a 114-kilodalton
protein is specifically recognized by parietal cell autoan-
tibodies present in patients with AIG,5–9 in some pa-
tients with gastritis associated with postpartum thyroid-
itis,4 and in a subgroup of H. pylori–infected patients
who develop parietal cell autoantibodies and mucosal
atrophy of the gastric corpus.32,33 Because human
H1,K1-ATPase (natural or cloned) was not available, the
porcine enzyme that can be purified in large amounts and
is at least 95% identical was used. The results of this
study suggest that human and porcine H1,K1-ATPase
share not only a number of B-cell epitopes recognized by
autoantibodies, but also T-cell epitopes that require their
coupling to MHC class II molecules on APCs to be
recognized by specific autologous T cells. The possibility
that our porcine H1,K1-ATPase preparation is contam-
inated by superantigens can be excluded on the basis of
the lack of response by gastric T-cell clones to H1,K1-
ATPase presented by allogeneic APCs and on the lack of
response by gastric T-cell clones isolated from H. pylori–
infected patients.
Figure 6. Ability of H1,K1-ATPase–specifi gastric T-cell clones from
patients with AIG to express antigen-induced perforin-mediated cyto-
toxicity against antigen-presenting autologous EBV-B cells. Cytolytic
activity of each H1,K1-ATPase–specifi clone was tested in triplicate
at an effector-to-target ratio of 10 to 1 against 51Cr-labeled autologous
EBV-B cells pulsed with H1,K1-ATPase (3 mg/mL) or with porcine
albumin (50 mg/mL). Percent of specifi 51Cr release was calculated
as described in Materials and Methods. The dotted lines indicate 5
SD above the mean spontaneous release of target cells alone.
Figure 7. Ability of H1,K1-ATPase–specifi gastric T-cell clones from
patients with AIG to induce Fas-Fas ligand–mediated apoptosis and
lysis in Jurkat cells in the presence of control mouse Ig or anti-Fas
mAb. Proapoptotic activity of each H1,K1-ATPase–specifi clone was
tested in triplicate at an effector-to-target ratio of 10 to 1 against
51Cr-labeled Jurkat cells in the absence or presence of 10 ng/mL PMA
and 1 mmol/L ionomycin. Percent of specifi 51Cr release was calcu-
lated as described in Materials and Methods. The dotted lines indi-
cate 5 SD above the mean spontaneous release of target cells alone.
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When assessed for their cytokine secretion profile,
most H1,K1-ATPase–specific T-cell clones generated
from the gastric mucosa of patients with AIG produced
IFN-g and TNF-a but neither IL-4 nor IL-5, thus
exhibiting a clear-cut Th1 pattern. The possibility that
this outcome does not reflect the real functional attitude
of the gastric T-cell counterparts in vivo, but is the result
of in vitro artifacts caused by the cloning procedure, was
considered. However, H. pylori–specific clones with pre-
dominant Th0 profile were generated from the gastric
mucosa of control patients with H. pylori–induced
chronic gastritis using the same cloning protocol. The
present results, showing that both Th1 and Th0 H1,K1-
ATPase–specific gastric T-cell clones are able to help
B-cell Ig production, suggest that chronic autoantigen-
induced T cell–dependent B-cell activation is probably
responsible for the local synthesis of H1,K1-ATPase
autoantibodies found in the sera.
T–B-cell interaction is a multistep process resulting in
B-cell help and/or B-cell death, depending on the func-
tional commitment of the helper T cells involved. In
vitro, a decrease in antigen-induced B-cell help at high
T-to-B cell ratios is peculiar to all Th1, and most Th0,
clones because of their concomitant expression of cyto-
lytic killing of antigen-presenting autologous B cells.24
Two complementary lytic pathways mediate T-cell cy-
totoxicity: the exocytosis of perforin-containing granules
on cognate target cells and the engagement of Fas on
cognate or neighboring target cells by Fas ligand,34,35
activities that are usually both expressed by Th1
clones.24,25,36 The ability of Th1 effector cells present in
the gastric mucosa to express cytolytic and proapoptotic
activity against autoantigen-presenting cells may repre-
sent a key mechanism in the mucosal atrophy of AIG.
Indeed, local IFN-g production by Th1 cells (possibly
potentiated by concomitant TNF-a production) can in-
crease the expression of MHC class II molecules by
gastric cells,37 which in turn would enable these cells to
present peptides of gastric autoantigens, including
H1,K1-ATPase, to T cells that differentiate into Th1
effector cells. Because gastric epithelial cells were also
found to express either B7-1 (CD80) or B7-2 (CD86)
costimulatory molecules, which are required for T-cell
activation, and are up-regulated after cross-linking of
MHC class II molecules and exposure to IFN-g,38 the
possibility that gastric epithelial cells act as antigen- or
autoantigen-presenting cells is real.
There is strong analogy between human chronic atro-
phic AIG and mouse postthymectomy EAIG.16 Suscep-
tible mice undergoing neonatal thymectomy spontane-
ously develop chronic atrophic gastritis and circulating
parietal cell autoantibodies that recognize the a and b
subunits of H1,K1-ATPase.39 Although autoantibodies
can appear at different stages of the disease,14,19 several
studies suggest that H1,K1-ATPase subunits are impor-
tant T-cell targets involved either in the development
or in the maintenance of EAIG in thymectomized
mice.17,40,41 A gastritogenic CD41 T-cell clone, estab-
lished from an EAIG thymectomized mouse, that recog-
nizes a peptide of the a subunit of H1,K1-ATPase in a
MHC class II–restricted manner was found to express the
Th1 cytokine profile. Adoptive transfer into syngeneic
nu/nu mice of this Th1 clone able to express Fas ligand
and to induce apoptosis in APCs resulted in gastritis
associated with loss of parietal cells.41 More recently, 2
gastritogenic H1,K1-ATPase a chain–specific T-cell
lines showing opposite Th1/Th2 profiles, both able to
induce severe destructive gastritis with parietal cell loss
in nu/nu mice, were established from thymectomized
mice. However, the Th2 line recruited a gastric infiltrate
composed by polymorphonuclear leukocytes and eosino-
phils, whereas the Th1-induced gastric infiltrate con-
sisted primarily of lymphocytes and monocytes, i.e., they
showed the typical pattern found in human AIG.17
In conclusion, the demonstration of H1,K1-ATPase–
specific autoreactive Th1 cytotoxic effector cells in the
target organ of AIG is consistent with previous data
showing predominance of Th1 responses in human thy-
roid autoimmune disorders,42,43 which are frequently
associated with AIG, and multiple sclerosis.44 Our
present data reinforce evidence accumulated in animal
models suggesting that experimental organ-specific au-
toimmune diseases, such as encephalomyelitis, thyroid-
itis, gastritis, insulin-dependent diabetes mellitus, and
myasthenia gravis, are mainly mediated by IFN-g–se-
creting Th1 cells.45,46 Our interpretation of the data is
that AIG is caused by parietal cell destruction by CD4
Th1 cells that recognize H1,K1-ATPase presented in the
context of MHC class II up-regulated by IFN-g on the
surface of parietal cells, whose destiny is death induced
by cytotoxic mediators and apoptosis.
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Halsted of the Halsted Suture
William Stewart Halsted (1852–1922) was born in New York City, the
scion of a prominent, affluent family. As an undergraduate at Yale, he was
more proficient at athletics than scholarship, yet in 1877 he graduated first
in his class at the College of Physicians and Surgeons of Columbia Uni-
versity. From a diligent tour of the major medical centers in Europe, he
acquired a passionate interest in clinical and laboratory investigation. Once
back in New York, he gained esteem as a practitioner and teacher but his
career seemed cut short when he was invalided by addiction to cocaine,
acquired in seeking relief from painful neuritis that had complicated a
finger infection. Nevertheless, at the urging of the pathologist William
Welch he moved to Baltimore and joined the staff of the Johns Hopkins
Hospital where he became surgeon-in-chief and established a pre-eminently
influential school of surgery. There, too, his affliction was compassionately
tended by his medical colleague William Osler. In addition to a method of
suture long used in gastrointestinal anastomoses, he introduced the use of
rubber gloves and devised a variety of innovative surgical instruments.
Meticulous in the handling of tissues, he was equally fastidious in his
personal attire and social conduct.
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